October 6, 2011
Cambridge, MA
Effective and cost-efficient legal guidance now, more than ever, is essential for the protection of innovator small molecule and biologic pharmaceutical products. During this program our panelists will discuss:
• An Overview of the Follow-On Biologics Framework
• Strategies for Successfully Litigating Hatch-Waxman and Biosimilar Cases
• Strategies for Maximizing Small Molecule and Biosimilar Patent Protection
Finnegan
55 Cambridge Parkway
Cambridge, MA 02142
Federal Circuit IP Blog
June 26, 2026
Federal Circuit IP Blog
June 26, 2026
Lecture
Latest Developments in U.S. Section 337 Investigations and Response Strategies
June 12, 2026
Dongguan
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.